MedTrace Logo

The Prolonged Effect of Consumption of a Partially Hydrolyzed Infant Formula During the First 6 Months of Life on the Development of Allergic Manifestations At 5 Years of Age

NCT05418491 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 455

Last updated 2025-03-13

No results posted yet for this study

Summary

The present study is a 5-year follow-up of the Allergy Reduction Trial (A.R.T.) birth cohort study of 551 infants at high-risk for allergy. The A.R.T. 5-year follow-up study, aims to investigate the prolonged effect of each feeding regimen \[formula-fed (exclusively or partially) with the partially hydrolyzed formula (pHF) or the standard formula (SF), or exclusively breastfed\] within the first 6 months of life on the development of any allergic manifestations up to the age of 5 years. Allergic manifestations within this time period will include the presence of any of the following: atopic dermatitis, food allergies, respiratory allergies, urticaria, drug allergy and insect venom allergy. In addition, differences on growth (weight, height, BMI) will be examined.

Conditions

  • Allergy

Interventions

OTHER

No intervention is used in the current study. Interventions were given in the original A.R.T. study

The current study is a post-intervention study; interventions were given in the original A.R.T. study

Sponsors & Collaborators

  • FrieslandCampina

    lead INDUSTRY

Principal Investigators

  • Yannis Manios, Dr. · Harokopio University

Eligibility

Min Age
5 Years
Max Age
63 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-21
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • Bulgaria
  • Cyprus
  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05418491 on ClinicalTrials.gov